Clinical Trials
11 trialsNCT06181032 2024-04-30
A Study of Adebrelimab in Combination With Apatinib Gemcitabine and Cisplatin in Biliary Tract Malignancies
First Affiliated Hospital of Fujian Medical University
Phase 1 Recruiting
NCT04393506 2023-11-22
Inductive Camrelizumab and Apatinib for Patients With Locally Advanced and Resectable Oral Squamous Cell Carcinoma
Shanghai Jiao Tong University School of Medicine
Phase 1 Completed
NCT05001412 2021-08-12
Chemotherapy Combined With Camrelizumab and Apatinib in First-line Treatment of ES-SCLC
Guangzhou Institute of Respiratory Disease
Phase 1 Unknown
NCT02645864 2021-03-18
Apatinib and Irinotecan Combination Treatment in Esophageal Squamous Cell Carcinoma
Peking University
Phase 1 Completed
NCT04665362 2021-01-22
IIT Study of M1-c6v1 Combined With SHR-1210 and Apatinib in Patients With HCC
Third Affiliated Hospital, Sun Yat-Sen University
Phase 1 Unknown
NCT03407976 2020-07-15
APPEASE
University of Utah
Phase 1 Terminated
NCT03645200 2019-04-25
Treatment of Carrying TP53 Harmful Mutations
Tianjin Medical University Second Hospital
Phase 1 Unknown
NCT03276156 2017-09-08
Apatinib in Combination With S-1 as Second-Line Treatment in Patients With Advanced Gastric Cancer
Zhejiang Cancer Hospital
Phase 1 Unknown
NCT03050411 2017-02-10
Apatinib Combine With EGFR-TKI for Advanced EGFR-TKI-resistant Non-Small Cell Lung Cancer
Peking University Third Hospital
Phase 1 Unknown
NCT02691871 2016-02-25
Apatinib Plus Docetaxel as 2nd Line Treatment in Patients With Advanced Lung Adenocarcinoma Harboring Wild-type EGFR
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 1 Unknown
NCT00633490 2008-07-22
Study of Apatinib as an Inhibitor of Tumor Angiogenesis
Fudan University
Phase 1 Unknown